Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Location
Frederick, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1116% % 75%
Debt-to-equity -887% % -11%
Return On Equity 280% % 103%
Return On Assets -36% % -79%
Operating Margin -5127% % -4445%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,509,024 shares 2.1%
Common Stock, Shares, Outstanding 26,011,106 shares 0.95%
Entity Public Float $108,739,558 USD -44%
Common Stock, Value, Issued $3,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 25,973,329 shares 50%
Weighted Average Number of Shares Outstanding, Diluted 25,973,329 shares 50%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,797,000 USD -93%
Revenue from Contract with Customer, Excluding Assessed Tax $400,000 USD -99%
Research and Development Expense $58,034,000 USD 29%
General and Administrative Expense $31,468,000 USD 4.5%
Operating Income (Loss) $143,405,000 USD -227%
Net Income (Loss) Attributable to Parent $130,302,000 USD -68%
Earnings Per Share, Basic -5.02 USD/shares -12%
Earnings Per Share, Diluted -5.02 USD/shares -12%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $125,139,000 USD -41%
Accounts Receivable, after Allowance for Credit Loss, Current $1,115,000 USD 28%
Assets, Current $129,276,000 USD -40%
Property, Plant and Equipment, Net $12,185,000 USD 23%
Operating Lease, Right-of-Use Asset $5,601,000 USD 1.2%
Goodwill $48,163,000 USD 0%
Other Assets, Noncurrent $5,551,000 USD
Assets $296,411,000 USD -32%
Accounts Payable, Current $1,288,000 USD 347%
Employee-related Liabilities, Current $3,985,000 USD 13%
Accrued Liabilities, Current $9,498,000 USD -21%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $14,937,000 USD -35%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Deferred Income Tax Liabilities, Net $6,948,000 USD -57%
Operating Lease, Liability, Noncurrent $8,525,000 USD -23%
Liabilities $422,651,000 USD -4.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,576,000 USD 0.97%
Retained Earnings (Accumulated Deficit) $822,373,000 USD -19%
Stockholders' Equity Attributable to Parent $126,240,000 USD -1756%
Liabilities and Equity $296,411,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,108,000 USD -45%
Net Cash Provided by (Used in) Financing Activities $8,025,000 USD -119%
Net Cash Provided by (Used in) Investing Activities $1,075,000 USD -79%
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 26,011,106 shares 0.95%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32,176,000 USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $126,874,000 USD -41%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $296,910,000 USD 20%
Deferred Tax Assets, Gross $319,800,000 USD 16%
Operating Lease, Liability $12,676,000 USD -9.4%
Depreciation $2,400,000 USD 100%
Payments to Acquire Property, Plant, and Equipment $1,075,000 USD 79%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $130,257,000 USD -68%
Lessee, Operating Lease, Liability, to be Paid $15,984,000 USD -13%
Property, Plant and Equipment, Gross $16,918,000 USD 38%
Operating Lease, Liability, Current $4,151,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,554,000 USD 0.35%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,740,000 USD 30%
Operating Lease, Weighted Average Discount Rate, Percent 0.121 pure 3.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,308,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,529,000 USD -42%
Deferred Tax Assets, Operating Loss Carryforwards $60,899,000 USD 38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9,427,168 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,630,000 USD -30%
Operating Lease, Payments $317,000 USD -58%
Additional Paid in Capital $700,706,000 USD 1.6%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $10,521,000 USD 60%
Interest Expense $2,025,000 USD -35%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%